Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Customs Customs + AT Customs - 1983 (11) TMI AT This

  • Login
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

1983 (11) TMI 305 - AT - Customs

Issues:
Whether the chemical Glyoxal 40% imported by the appellants qualifies for exemption from additional duty of customs as a "drug intermediate" under Central Excise Notification No. 55/75.

Analysis:
The appeals were transferred to the Tribunal for disposal under Section 131B(2) of the Customs Act, 1962. The central issue in all three appeals was the eligibility of Glyoxal 40% for exemption as a "drug intermediate" under the Central Excise Notification. The lower authorities contended that since Glyoxal 40% had multifarious uses and was not predominantly used in drug manufacturing, it did not qualify for the exemption.

During the hearing, the appellants argued that Glyoxal 40% was used in the manufacture of Metronidazole I.P., a drug for which they held a license. They claimed that Glyoxal 40% met the criteria of a "drug intermediate" under the notification based on its predominant use in drug manufacturing. They also presented evidence of indigenous Glyoxal 40% being assessed at nil duty under the same notification.

The respondent argued that the term "intermediate" was not defined in the notification and referred to standard definitions to support their stance. They contended that Glyoxal 40% had various uses beyond drug manufacturing, and its predominant use could not be established. They also cited a book that identified Imidazole, not Glyoxal 40%, as a drug intermediate.

The Tribunal considered the submissions of both parties and noted that the Appellate Collector had previously acknowledged the principal use of Glyoxal 40% in drug manufacturing. The Tribunal found no evidence to rebut this claim and highlighted the classification of Glyoxal 40% by Rajasthan Central Excise authorities under the same notification. The Tribunal interpreted the meaning of "intermediate" based on various authoritative sources and concluded that Glyoxal 40% qualified as a drug intermediate.

In light of the evidence and definitions presented, the Tribunal allowed the appeals and directed the customs authorities to grant consequential relief to the appellants within three months.

 

 

 

 

Quick Updates:Latest Updates